Clear Street Markets LLC Gilead Sciences, Inc. Transaction History

Clear Street Markets LLC

$529 Million
Q2 2024

A detailed history of Clear Street Markets LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Clear Street Markets LLC holds 1,965 shares of GILD stock, worth $166,514. This represents 0.03% of its overall portfolio holdings.

Number of Shares

1,965

Previous 9,100 78.41%

Holding current value

$166,514

Previous $667,000 79.76%

% of portfolio

0.03%

Previous 0.11%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 26, 2024	SELL	$63.15 - $72.88 $450,575 - $519,998	-7,135 Reduced 78.41%	1,965 $135,000
Q1 2024 May 13, 2024	BUY	$71.58 - $87.29 $365,058 - $445,179	5,100 Added 127.5%	9,100 $667,000
Q4 2023 Feb 13, 2024	SELL	$73.27 - $83.09 $259,375 - $294,138	-3,540 Reduced 46.95%	4,000 $324,000
Q3 2023 Nov 13, 2023	BUY	$73.94 - $80.67 $97,378 - $106,242	1,317 Added 21.16%	7,540 $565,000
Q2 2023 Aug 14, 2023	BUY	$76.01 - $86.7 $32,152 - $36,674	423 Added 7.29%	6,223 $480,000
Q1 2023 May 12, 2023	SELL	$77.31 - $88.08 $5.03 Million - $5.73 Million	-65,100 Reduced 91.82%	5,800 $481,000
Q4 2022 Feb 13, 2023	BUY	$62.32 - $89.47 $3.81 Million - $5.47 Million	61,177 Added 629.2%	70,900 $6.09 Million
Q3 2022 Nov 02, 2022	SELL	$59.54 - $68.01 $46,262 - $52,843	-777 Reduced 7.4%	9,723 $600,000
Q2 2022 Aug 02, 2022	SELL	$57.72 - $65.01 $131,024 - $147,572	-2,270 Reduced 17.78%	10,500 $649,000
Q1 2022 May 11, 2022	SELL	$57.92 - $72.58 $4.32 Million - $5.41 Million	-74,544 Reduced 85.37%	12,770 $759,000
Q4 2021 Jan 18, 2022	BUY	$64.88 - $73.64 $270,809 - $307,373	4,174 Added 5.02%	87,314 $6.34 Million
Q3 2021 Oct 20, 2021	BUY	$67.69 - $73.03 $2.01 Million - $2.17 Million	29,761 Added 55.75%	83,140 $5.81 Million
Q2 2021 Jul 19, 2021	BUY	$63.47 - $69.35 $1.65 Million - $1.8 Million	25,979 Added 94.81%	53,379 $3.68 Million
Q1 2021 Apr 14, 2021	SELL	$60.0 - $68.46 $1.82 Million - $2.08 Million	-30,400 Reduced 52.6%	27,400 $1.77 Million
Q4 2020 Feb 25, 2021	SELL	$56.65 - $64.55 $11,330 - $12,910	-200 Reduced 0.34%	57,800 $3.37 Million
Q3 2020 Oct 19, 2020	BUY	$62.1 - $78.08 $1.06 Million - $1.33 Million	17,000 Added 41.46%	58,000 $3.67 Million
Q2 2020 Aug 06, 2020	BUY	$72.34 - $84.0 $2.36 Million - $2.74 Million	32,600 Added 388.1%	41,000 $3.16 Million
Q1 2020 Apr 28, 2020	SELL	$62.63 - $80.22 $688,930 - $882,420	-11,000 Reduced 56.7%	8,400 $628,000
Q4 2019 Jan 13, 2020	BUY	$61.62 - $67.78 $616,200 - $677,800	10,000 Added 106.38%	19,400 $1.26 Million
Q3 2019 Oct 18, 2019	SELL	$62.51 - $69.0 $156,275 - $172,500	-2,500 Reduced 21.01%	9,400 $596,000
Q2 2019 Jul 16, 2019	SELL	$61.87 - $69.38 $1.98 Million - $2.22 Million	-32,000 Reduced 72.89%	11,900 $804,000
Q1 2019 May 09, 2019	BUY	$62.53 - $70.05 $1.09 Million - $1.22 Million	17,400 Added 65.66%	43,900 $2.85 Million
Q4 2018 Jan 23, 2019	SELL	$60.54 - $79.0 $127,134 - $165,900	-2,100 Reduced 7.34%	26,500 $1.66 Million
Q3 2018 Nov 13, 2018	BUY	$71.28 - $78.92 $1.01 Million - $1.12 Million	14,200 Added 98.61%	28,600 $2.21 Million
Q2 2018 Jul 27, 2018	SELL	$64.88 - $75.68 $486,599 - $567,600	-7,500 Reduced 34.25%	14,400 $1.02 Million
Q1 2018 May 01, 2018	BUY	$72.84 - $88.8 $1.03 Million - $1.26 Million	14,200 Added 184.42%	21,900 $1.65 Million
Q4 2017 Feb 01, 2018	SELL	$71.15 - $83.52 $2.48 Million - $2.91 Million	-34,800 Reduced 81.88%	7,700 $552,000
Q3 2017 Oct 30, 2017	BUY	$72.11 - $85.47 $3.06 Million - $3.63 Million	42,500	42,500 $3.44 Million

Others Institutions Holding GILD

# of Institutions

1,879

Shares Held

1.02B

Call Options Held

12M

Put Options Held

8.96M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $106B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Clear Street Markets LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clear Street Markets LLC with notifications on news.

Account

Clear Street Markets LLC Gilead Sciences, Inc. Transaction History